Basic Debrief

Basic Debrief 2019

NAFLD Debrief PDF

Hepatitis Debrief 2019

Clinical Hepatology Debrief 2019

Alcoholic Hepatitis Leading to ACLF: Current Therapy and Recommendations

Alcoholic Hepatitis Leading to ACLF: Current Therapy and Recommendations SLIDES

Liver Transplantation for ACLF: North American Experience SLIDES

ALF and Systemic Hyperinflammation: Phenotypic Similarities and Therapeutic Implications SLIDES

Acute-on-Chronic Liver Failure: Drivers and Consequences of Serious Acute Decompensation in Cirrhosis SLIDES

Beyond Traditional Supportive Care in ALF: Hemofiltration, Bio-assist Devices and Cell Transplant SLIDES

Cirrhotic Cardiomyopathy PDF

The Case for Value-Based Care PDF

How Can Hepatologists Contribute to Success in Value-Based Care PDF

Developing an APM for Advanced Liver Disease PDF

The Role of Palliative Care in High-Value Hepatology Care PDF

Telehealth for High-Value Liver Care PDF

Distributed Hepatocytes in Liver Homeostasis and Regeneration

Molecular Pathogenesis and Management of Hepatocellular Carcinoma PDF

Clinical Vs Science in Personalizing Immunosuppression PDF

Precision Hepatology in Clinical Practice Introduction to Course

NAFLD Debrief

Liver Transplantation for ACLF: North American Experience

Genetic Susceptibility to Drug Induced Liver Injury

The Spectrum of Precision Medicine

Hepatitis Debrief

ALF and Systemic Hyperinflammation: Phenotypic Similarities and Therapeutic Implications

Molecular Pathogenesis and Management of Hepatocellular Carcinoma

Influence of the Microbiome on Liver Disease Phenotype and Outcome

Clinical Hepatology Debrief

Acute-on-Chronic Liver Failure: Drivers and Consequences of Serious Acute Decompensation in Cirrhosis

Clinical Vs Science in Personalizing Immunosuppression

Precision Medicine and Patients at Risk for Drug-induced Liver Injury*

Beyond Traditional Supportive Care in ALF: Hemofiltration, Bio-assist Devices and Cell Transplant

Clinical Models and Risk Assessment: Acute-on-Chronic Liver Failure as a Paradigm

Navigating Liver Transplant Decision in PALF

Non-alcoholic Fatty Liver Disease: Non-invasive Phenotyping

Pathophysiology of Sodium Retention and Kidney Dysfunction in Cirrhotic Ascites

Phenotyping NAFLD: Risk Stratification and Managing Co-Morbidities*

Prevention of Ascites in Cirrhosis: What's New?

Reversing Liver Fibrosis: Predicting and Monitoring Structural Changes*

Inflammation and Beyond: Additional Pathophysiological Mechanisms of AKI

Precision Therapy in Patients with Primary Biliary Cholangitis*

Management of the Failing Kidney in Cirrhosis: The ICU Perspective

Predictors of Disease Progression and Complications of Primary Sclerosing Cholangitis

When All Else Fails: Evolving Indications for SLKT

Autoimmune Liver Disease in Younger Patient: Crossing Phenotypic Boundaries*

Case Directed Discussion: ACLF Due to AKI/HRS

Biliary Atresia: Biomarkers of Disease and Predictors of Outcome*

Hepatocellular Carcinoma Practice Guidance 2018

Managing HCV Cirrhotic Patients After Achieving SVR: Who Will Progress to Developing Hepatocellular Carcinoma?*

Primary Biliary Cholangitis Practice Guidance 2018

Non-invasive Assessment of Small Liver Lesions

Alcohol-Related Liver Disease Practice Guidance 2018

Precision Medicine to Guide Therapy in Liver Cancer

Drugs Targeted at the Gut-liver Axis

Emerging Treatment Options for HCC and Cholangiocarcinoma*

Drugs Targeted to Enhance Hepatic Regeneration

Genetic Testing in Adults with Liver Disease: Improving Diagnostic Algorithms

Management of Alcohol Use Disorder Before and After Transplantation

Precision Treatment of HBV: Envisioning Curative Therapies*

Current Clinical Trials Design: Fresh Look at the Old Problem

Personalizing Longitudinal Care of Patients with Cirrhosis

Should I Do a Transplant Hepatology Fellowship?

Case-based Debate: Balancing the Costs and Benefits of Individualized Medicine*

How to Be a Good Mentee and Identify Mentors/Sponsors to Launch Your Career

Case-based Debate: Balancing the Costs and Benefits of Individualized Medicine* 2

Contract Negotiations and Other Considerations for Your First Job

From Discovery Science to Clinical Care: Where Do We Want to Go?

How I Make Time for Myself and My Work

A Day in the Life of a Basic Scientist

A Day in the Life of a Community-based Hepatologist

A Day in the Life of an Academic Hepatologist

Overview of Bile Acid Receptors

Bile Acid Signaling in Genetic Cholestatic Syndromes

Ursodiol: 20 Years of Experience: Where Do We Stand?

Therapeutic Benefits of Statin in Chronic Liver Diseases

Primary and Secondary Prophylaxis of Gastric Variceal Bleeding

Management of Coagulopathy in Cirrhosis

Treatment of HCV in PWID

Identify the Gap: Why Study the Microbiome in Liver Disease

Methods and Setup for Microbiome Research

Bioinformatics and How to Find Collaborators: Innovative Tools to Study the Microbiome

Creating Solutions for Racial and Ethnic Disparities in Health

Culture Context for Patient Care in Liver Transplantation: Northwestern Hispanic Transplant Program

Community-based Interventions for Eliminating Liver Cancer: SF CAN Liver Cancer Group

Partnership in Viral Hepatitis Elimination: Alaskan Native Viral Hepatitis Program

HCV+ Donors in Liver Transplantation

HCV+ Donors in Renal Transplantation

HCV+ Donors in Heart/Lung Transplantation

Ethical & Practical Considerations in Transplantation from HCV+ Donors

Debate (PRO): HCV+ Donation is No Longer Research and is Ready to Move to Standard of Care

Debate (CON): HCV+ Donation Is No Longer Research and Is Ready to Move to Standard of Care

Cirrhotic Cardiomyopathy

Global Burden, Social and Economic Impact of Alcoholic Liver Disease

AASLD/U.S. Perspective

Current Therapies - Guidelines, Pitfalls and the "Gray Zone"

Emerging Therapies - Updates in HBV Cure

Barriers and Strategies for HCC Prevention - Can HCC Risk Score Help Us?

Current State of the HCV Care Cascade

Novel Tests and Strategies in HCV Screening

Novel Models of HCV Care Delivery

Co-Localization in HCV Care

Current Status of U.S. and Global Drug Access

Epidemiology of Obesity, Diabetes and HCC World Wide

Rationale for Surveillance in HCC for Patients with NASH/Metabolic Syndrome

Diagnosis and Management of HCC in Obesity

Welcome and Introductions

Clinical Pearls for Management of Child's B/C Cirrhotic

Controversies in Cirrhosis

Long Term Care of the Transplant Patient

Getting the NASH/Obese Patient to Transplant

Patient Case Studies

Assessment of Abnormal Liver Biochemistries

Management and Outcomes in Local Regional Therapy for HCC

Hepatitis B Update

Readmissions: Incidents, Risk Factors and Cost?

Drugs at Discharge: Get it Straight

Transitions in Care: Whose Patient is it Anyway?

Dose, Duration and Drug Characteristics as Risk Factors for Liver Injury

Resources to Help the Clinician Manage Hepatotoxicity: Focus on LIVERTOX

Setting up Your Twitter, Sending Your First Tweet

Twitter As a Trainee

Running a Divisional Twitter Account

Running a Journal’s Twitter Account

#Tweetorials: Twitter As an Educator

Basic Concepts of Liver Regeneration

Long-Noncoding RNA Regulation of Liver Fibrosis

Allocation for Optimizing Long-term Outcomes in Children

Allocation for Optimizing Long-term Outcomes in Adults

The Genetic Signatures of Tolerant and Non-tolerant Allografts

Chronic Antibody-mediated Rejection: Detection and Treatment

Assessing and Addressing Liver Fibrosis in the Allograft

Precision Immunosuppression

Updates: ABIM Policy and AASLD Support

Updates: ABIM Policy and AASLD Support 2

What Do I Need to Remain Certified and How Can I Get MOC Points?

What Is the National Board of Physicians and Surgeons?

Mini-MOC: Case-based Board Style Questions

HCC Prevention, Biomarkers and Community Outreach – Highlights from the NCI

NIAAA Alcohol Treatment Navigator – Tools for Providers and Patients

Gut Microbiome, Nuclear Hormone Receptors and Liver Fibrosis

Gut Microbiome as a Prediction of Efficacy of Weight Loss Strategies

Lessons from Global Health

Global Epidemiology of Liver Disease

Novel Approaches to Screen for Liver Disease in the General Population

Screening for Viral Hepatitis in Special Populations (Minorities, Immigrants, PWID)

Cost Effectiveness of Screening and Linkage to Care

Surgical Considerations

Assessing Cardiopulmonary Reserve & Renal Function

Early Challenges Post-Operatively

Optimizing Management for the Long-Term & The Problem of Post-Transplant Recurrence

Case Presentation Stimulated Panel Discussion/ Q&A

The Role of Bariatric Surgery: Timing and Technique

Debate: Post Transplant Recurrence: We Can Prevent It!

Debate: Post Transplant Recurrence: Does it Matter??

Rebuttal: Does it Matter??

Rebuttal: We Can Prevent It!

The Case for Value-Based Care

How Can Hepatologists Contribute to Success in Value-Based Care

Developing an APM for Advanced Liver Disease

The Role of Palliative Care in High-Value Hepatology Care

Telehealth for High-Value Liver Care

Fertility and Contraception in Liver Disease: Recommendations for Hepatic Adenomas, Cirrhosis and Liver Transplant

Management and Outcomes in Portal Hypertension in Pregnancy

Pregnancy in Transplant Recipients: Preconception Care and Maternal and Fetal Outcomes

Chronic Liver Disease in Pregnancy: A Focus on Autoimmune Disease and Viral Hepatitis

Panel Discussion/ Challenging Cases